Mesenchymal stem cells induce granulocytic differentiation of acute promyelocytic leukemic cells via IL-6 and MEK/ERK pathways

Stem Cells and Development

Volumn 22, Issue 13, 2013, Pages 1955-1967

  Chen, Fang ^a   Zhou, Kang ^a   Zhang, Lei ^a   Ma, Fengxia ^a   Chen, Dandan ^a   Cui, Junjie ^a   Feng, Xiaoming ^a   Yang, Shaoguang ^a   Chi, Ying ^a   Han, Zhibo ^a,b   Xue, Feng ^a   Rong, Lijuan ^a   Ge, Meili ^a   Wan, Li ^a   Xu, Shuxia ^a   Du, Wenjing ^a   Lu, Shihong ^a   Ren, Hongying ^a   Han, Zhongchao ^a,b  

^a PEKING UNION MEDICAL COLLEGE   (China)

^b Amcellgene Co Ltd   (China)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR ALPHA; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; RETINOIC ACID;

ARTICLE; CANCER CELL CULTURE; CELL DIFFERENTIATION; COMPETITIVE INHIBITION; CONTROLLED STUDY; GRANULOCYTE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; SIGNAL TRANSDUCTION; UMBILICAL CORD BLOOD;

CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL- AND TISSUE-BASED THERAPY; GRANULOCYTES; HUMANS; INTERLEUKIN-6; LEUKEMIA, PROMYELOCYTIC, ACUTE; MAP KINASE SIGNALING SYSTEM; MESENCHYMAL STROMAL CELLS; TRETINOIN; UMBILICAL CORD;

EID: 84879368649     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2012.0621     Document Type: Article

References (69)

1. Lanotte M, V Martin-Thouvenin, S Najman, P Balerini, F Valensi and R Berger. (1991). NB4, a maturation inducible cell line with t(15;17) marker isolated from a human acute promyelocytic leukemia (M3). Blood 77:1080-1086.
2. Warrell RP, Jr., SR Frankel, WH Miller, Jr., DA Scheinberg, LM Itri, WN Hittelman, R Vyas, M Andreeff, A Tafuri, et al. (1991). Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). N Engl J Med 324:1385-1393.
3. De Botton S, H Dombret, M Sanz, JS Miguel, D Caillot, R Zittoun, M Gardembas, A Stamatoulas, E Conde, et al. (1998). Incidence, clinical features, and outcome of all transretinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 92:2712-2718. (Pubitemid 28469083)
4. Tallman MS, JW Andersen, CA Schiffer, FR Appelbaum, JH Feusner, A Ogden, L Shepherd, JM Rowe, C Francois, RS Larson and PH Wiernik. (2000). Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 95:90-95. (Pubitemid 30017230)
5. Vahdat L, P Maslak, WH Miller, Jr., A Eardley, G Heller, DA Scheinberg and RP Warrell, Jr. (1994). Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Blood 84:3843-3849.
6. Smith-Whitley K and B Lange. (1993). Fatal all-trans retinoic acid pneumonitis. Ann Intern Med 118:472-473. (Pubitemid 23081061)
7. Fenaux P, C Chastang, S Chevret, M Sanz, H Dombret, E Archimbaud, M Fey, C Rayon, F Huguet, et al. (1999). A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group. Blood 94:1192-1200. (Pubitemid 29380399)
8. Avvisati G, F Lo Coco, D Diverio, M Falda, F Ferrara, M Lazzarino, D Russo, MC Petti and F Mandelli. (1996). AIDA (all-trans retinoic acid + idarubicin) in newly diagnosed acute promyelocytic leukemia: a Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) pilot study. Blood 88:1390-1398. (Pubitemid 26276815)
9. Mandelli F, D Diverio, G Avvisati, A Luciano, T Barbui, C Bernasconi, G Broccia, R Cerri, M Falda, et al. (1997). Molecular remission in PML/RAR alpha-positive acute promyelocytic leukemia by combined all-trans retinoic acid and idarubicin (AIDA) therapy. Gruppo Italiano-Malattie Ematologiche Maligne dell'Adulto and Associazione Italiana di Ematologia ed Oncologia Pediatrica Cooperative Groups. Blood 90:1014-1021. (Pubitemid 27314135)
10. Asou N, K Adachi, J Tamura, A Kanamaru, S Kageyama, A Hiraoka, E Omoto, H Akiyma, K Tsubaki, et al. (1998). Analysis of prognostic factors in newly diagnosed acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy. Japan Adult Leukemia Study Group. J Clin Oncol 16:78-85. (Pubitemid 28041582)
11. Wang ZY and Z Chen. (2008). Acute promyelocytic leukemia: from highly fatal to highly curable. Blood 111:2505-2515.
12. Gallagher RE. (2002). Retinoic acid resistance in acute promyelocytic leukemia. Leukemia 16:1940-1958. (Pubitemid 35203437)
13. Adamson PC, JF Boylan, FM Balis, RF Murphy, KA Godwin, LJ Gudas and DG Poplack. (1993). Time course of induction of metabolism of all-trans-retinoic acid and the up-regulation of cellular retinoic acid-binding protein. Cancer Res 53: 472-476. (Pubitemid 23059422)
14. Gianni M, M Terao, S Zanotta, T Barbui, A Rambaldi and E Garattini. (1994). Retinoic acid and granulocyte colonystimulating factor synergistically induce leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood 83:1909-1921. (Pubitemid 24107916)
15. Gianni M, M Terao, P Norio, T Barbui, A Rambaldi and E Garattini. (1995). All-trans retinoic acid and cyclic adenosine monophosphate cooperate in the expression of leukocyte alkaline phosphatase in acute promyelocytic leukemia cells. Blood 85:3619-3635.
16. Gianni M, Y Kalac, I Ponzanelli, A Rambaldi, M Terao and E Garattini. (2001). Tyrosine kinase inhibitor STI571 potentiates the pharmacologic activity of retinoic acid in acute promyelocytic leukemia cells: effects on the degradation of RARalpha and PML-RARalpha. Blood 97:3234-3243.
17. Pisano C, P Kollar, M Gianni, Y Kalac, V Giordano, FF Ferrara, R Tancredi, A Devoto, A Rinaldi, et al. (2002). Bisindols: a novel class of molecules enhancing the cytodifferentiating properties of retinoids in myeloid leukemia cells. Blood 100:3719-3730. (Pubitemid 35303944)
18. Bastie JN,NBalitrand, IGuillemot, CChomienne and LDelva. (2005). Cooperative action of 1alpha,25-dihydroxyvitamin D3 and retinoic acid in NB4 acute promyelocytic leukemia cell differentiation is transcriptionally controlled. Exp Cell Res 310:319-330. (Pubitemid 41457337)
19. Sanchez Y, D Amran, E de Blas and P Aller. (2009). Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4): protein kinase modulation and reactive oxygen species generation. Biochem Pharmacol 77:384-396.
20. Gu ZM, YL Wu, MY Zhou, CX Liu, HZ Xu, H Yan, Y Zhao, Y Huang, HD Sun and GQ Chen. (2010). Pharicin B stabilizes retinoic acid receptor-alpha and presents synergistic differentiation induction with ATRA in myeloid leukemic cells. Blood 116:5289-5297.
21. Kadiyala S, RG Young, MA Thiede and SP Bruder. (1997). Culture expanded canine mesenchymal stem cells possess osteochondrogenic potential in vivo and in vitro. Cell Transplant 6:125-134. (Pubitemid 27188295)
22. Zappia E, S Casazza, E Pedemonte, F Benvenuto, I Bonanni, E Gerdoni, D Giunti, A Ceravolo, F Cazzanti, et al. (2005). Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy. Blood 106:1755-1761. (Pubitemid 41208591)
23. Le Blanc K, I Rasmusson, B Sundberg, C Gotherstrom, M Hassan, M Uzunel and O Ringden. (2004). Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells. Lancet 363:1439-1441. (Pubitemid 38586721)
24. Khakoo AY, S Pati, SA Anderson, W Reid, MF Elshal, Rovira, II, AT Nguyen, D Malide, CA Combs, et al. (2006). Human mesenchymal stem cells exert potent antitumorigenic effects in a model of Kaposi's sarcoma. J Exp Med 203:1235-1247. (Pubitemid 43736593)
25. Ramasamy R, EW Lam, I Soeiro, V Tisato, D Bonnet and F Dazzi. (2007). Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth. Leukemia 21:304-310. (Pubitemid 46158124)
26. Yu JM, ES Jun, YC Bae and JS Jung. (2008). Mesenchymal stem cells derived from human adipose tissues favor tumor cell growth in vivo. Stem Cells Dev 17:463-473. (Pubitemid 351948199)
27. Zhu Y, Z Sun, Q Han, L Liao, J Wang, C Bian, J Li, X Yan, Y Liu, C Shao and RC Zhao. (2009). Human mesenchymal stem cells inhibit cancer cell proliferation by secreting DKK-1. Leukemia 23:925-933.
28. Dasari VR, KK Velpula, K Kaur, D Fassett, JD Klopfenstein, DH Dinh, M Gujrati and JS Rao. (2010). Cord blood stem cell-mediated induction of apoptosis in glioma downregulates X-linked inhibitor of apoptosis protein (XIAP). PloS One 5:e11813.
29. Tian LL, W Yue, F Zhu, S Li and W Li. (2011). Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo. J Cell Physiol 226:1860-1867.
30. Berardi AC, E Meffre, F Pflumio, A Katz, W Vainchenker, C Schiff and L Coulombel. (1997). Individual CD34 + CD38lowCD19-CD10-progenitor cells from human cord blood generate B lymphocytes and granulocytes. Blood 89:3554-3564. (Pubitemid 27227078)
31. Fluckiger AC, E Sanz, M Garcia-Lloret, T Su, QL Hao, R Kato, S Quan, A de la Hera, GM Crooks, ON Witte and DJ Rawlings. (1998). In vitro reconstitution of human B-cell ontogeny: from CD34( + ) multipotent progenitors to Ig-secreting cells. Blood 92:4509-4520.
32. Cheng L, P Qasba, P Vanguri and MA Thiede. (2000). Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34( + ) hematopoietic progenitor cells. J Cell Physiol 184:58-69. (Pubitemid 30349628)
33. Angelopoulou M, E Novelli, JE Grove, HM Rinder, C Civin, L Cheng and DS Krause. (2003). Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol 31:413-420. (Pubitemid 36579367)
34. da Silva CL, R Goncalves, KB Crapnell, JM Cabral, ED Zanjani and G Almeida-Porada. (2005). A human stromalbased serum-free culture system supports the ex vivo expansion/maintenance of bone marrow and cord blood hematopoietic stem/progenitor cells. Exp Hematol 33:828-835. (Pubitemid 40826597)
35. Briquet A, S Dubois, S Bekaert, M Dolhet, Y Beguin and A Gothot. (2010). Prolonged ex vivo culture of human bone marrow mesenchymal stem cells influences their supportive activity toward NOD/SCID-repopulating cells and committed progenitor cells of B lymphoid and myeloid lineages. Haematologica 95:47-56.
36. Lu LL, YJ Liu, SG Yang, QJ Zhao, X Wang, W Gong, ZB Han, ZS Xu, YX Lu, et al. (2006). Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica 91:1017-1026.
37. Dalton WT, Jr., MJ Ahearn, KB McCredie, EJ Freireich, SA Stass and JM Trujillo. (1988). HL-60 cell line was derived from a patient with FAB-M2 and not FAB-M3. Blood 71:242-247. (Pubitemid 18050420)
38. Khanna-Gupta A, K Kolibaba, TA Zibello and N Berliner. (1994). NB4 cells show bilineage potential and an aberrant pattern of neutrophil secondary granule protein gene expression. Blood 84:294-302. (Pubitemid 24193833)
39. Degos L and ZY Wang. (2001). All trans retinoic acid in acute promyelocytic leukemia. Oncogene 20:7140-7145. (Pubitemid 33107374)
40. Koeffler HP, J Ranyard and M Pertcheck. (1985). Myeloperoxidase: its structure and expression during myeloid differentiation. Blood 65:484-491. (Pubitemid 15163590)
41. Bentley DL and M Groudine. (1986). A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 321:702-706. (Pubitemid 16044131)
42. Scott LM, CI Civin, P Rorth and AD Friedman. (1992). A novel temporal expression pattern of three C/EBP family members in differentiating myelomonocytic cells. Blood 80:1725-1735.
43. Duprez E, K Wagner, H Koch and DG Tenen. (2003). C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. EMBO J 22:5806-5816. (Pubitemid 37408819)
44. Park DJ, AM Chumakov, PT Vuong, DY Chih, AF Gombart, WH Miller, Jr., and HP Koeffler. (1999). CCAAT/enhancer binding protein epsilon is a potential retinoid target gene in acute promyelocytic leukemia treatment. J Clin Invest 103:1399-1408. (Pubitemid 29535496)
45. Morosetti R, DJ Park, AM Chumakov, I Grillier, M Shiohara, AF Gombart, T Nakamaki, K Weinberg and HP Koeffler. (1997). A novel, myeloid transcription factor, C/EBP epsilon, is upregulated during granulocytic, but not monocytic, differentiation. Blood 90:2591-2600. (Pubitemid 27413468)
46. Imaizumi M, A Sato, Y Koizumi, S Inoue, H Suzuki, N Suwabe, M Yoshinari, R Ichinohasama, K Endo, et al. (1994). Potentiated maturation with a high proliferating activity of acute promyelocytic leukemia induced in vitro by granulocyte or granulocyte/macrophage colony-stimulating factors in combination with all-trans retinoic acid. Leukemia 8:1301-1308.
47. Maun NA, P Gaines, A Khanna-Gupta, T Zibello, L Enriquez, L Goldberg and N Berliner. (2004). G-CSF signaling can differentiate promyelocytes expressing a defective retinoic acid receptor: evidence for divergent pathways regulating neutrophil differentiation. Blood 103:1693-1701. (Pubitemid 38268961)
48. Rocca B, R Morosetti, A Habib, N Maggiano, F Zassadowski, G Ciabattoni, C Chomienne, B Papp and FO Ranelletti. (2004). Cyclooxygenase-1, but not-2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation. Leukemia 18:1373-1379. (Pubitemid 39136747)
49. Xie P, FS Chan, NY Ip and MF Leung. (2000). IL-6 enhanced the retinoic acid-induced differentiation of human acute promyelocytic leukemia cells. Cancer Lett 148:207-213. (Pubitemid 30047109)
50. Friedman R, M Betancur, L Boissel, H Tuncer, C Cetrulo and H Klingemann. (2007). Umbilical cord mesenchymal stem cells: adjuvants for human cell transplantation. Biol Blood Marrow Transplant 13:1477-1486. (Pubitemid 350091385)
51. Tasaki J, N Shibata, O Nishimura, K Itomi, Y Tabata, F Son, N Suzuki, R Araki, M Abe, K Agata and Y Umesono. (2011). ERK signaling controls blastema cell differentiation during planarian regeneration. Development 138:2417-2427.
52. Gu H, F Guo, X Zhou, L Gong, Y Zhang, W Zhai, L Chen, L Cen, S Yin, J Chang and L Cui. (2011). The stimulation of osteogenic differentiation of human adipose-derived stem cells by ionic products from akermanite dissolution via activation of the ERK pathway. Biomaterials 32:7023-7033.
53. Miranda MB, TF McGuire and DE Johnson. (2002). Importance of MEK-1/-2 signaling in monocytic and granulocytic differentiation of myeloid cell lines. Leukemia 16: 683-692. (Pubitemid 34449751)
54. Racke FK, K Lewandowska, S Goueli and AN Goldfarb. (1997). Sustained activation of the extracellular signalregulated kinase/mitogen-activated protein kinase pathway is required for megakaryocytic differentiation of K562 cells. J Biol Chem 272:23366-23370. (Pubitemid 27392477)
55. Woessmann W and NF Mivechi. (2001). Role of ERK activation in growth and erythroid differentiation of K562 cells. Exp Cell Res 264:193-200. (Pubitemid 32980224)
56. Yen A, MS Roberson, S Varvayanis and AT Lee. (1998). Retinoic acid induced mitogen-activated protein (MAP)/extracellular signal-regulated kinase (ERK) kinasedependent MAP kinase activation needed to elicit HL-60 cell differentiation and growth arrest. Cancer Res 58:3163-3172. (Pubitemid 28335101)
57. Scholl S, T Bondeva, Y Liu, JH Clement, K Hoffken and R Wetzker. (2008). Additive effects of PI3-kinase and MAPK activities on NB4 cell granulocyte differentiation: potential role of phosphatidylinositol 3-kinase gamma. J Cancer Res Clin Oncol 134:861-872.
58. Glasow A, N Prodromou, K Xu, M von Lindern and A Zelent. (2005). Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways. Blood 105:341-349. (Pubitemid 40053102)
59. Li Y, DJ Samuvel, KP Sundararaj, MF Lopes-Virella and Y Huang. (2010). IL-6 and high glucose synergistically upregulate MMP-1 expression by U937 mononuclear phagocytes via ERK1/2 and JNK pathways and c-Jun. J Cell Biochem 110:248-259.
60. Suzuki T, N Yoshinaga and S Tanabe. (2011). Interleukin-6 (IL-6) regulates claudin-2 expression and tight junction permeability in intestinal epithelium. J Biol Chem 286:31263-31271.
61. Yan J, OK Melemedjian, TJ Price and G Dussor. (2012). Sensitization of dural afferents underlies migraine-related behavior following meningeal application of interleukin-6 (IL-6). Mol Pain 8:6.
62. Tian K, S Yang, Q Ren, Z Han, S Lu, F Ma and L Zhang. (2010). p38 MAPK contributes to the growth inhibition of leukemic tumor cells mediated by human umbilical cord mesenchymal stem cells. Cell Physiol Biochem 26:799-808.
63. Baksh D, R Yao and RS Tuan. (2007). Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow. Stem Cells 25:1384-1392. (Pubitemid 47106005)
64. Cheng YC, H Lin, MJ Huang, JM Chow, S Lin and HE Liu. (2007). Downregulation of c-Myc is critical for valproic acidinduced growth arrest and myeloid differentiation of acute myeloid leukemia. Leuk Res 31:1403-1411. (Pubitemid 47212434)
65. Luo H, Q Li, J O'Neal, F Kreisel, MM Le Beau and MH Tomasson. (2005). c-Myc rapidly induces acute myeloid leukemia in mice without evidence of lymphoma-associated antiapoptotic mutations. Blood 106:2452-2461. (Pubitemid 41510820)
66. Huang MJ, YC Cheng, CR Liu, S Lin and HE Liu. (2006). A small-molecule c-Myc inhibitor, 10058-F4, induces cell-cycle arrest, apoptosis, and myeloid differentiation of human acute myeloid leukemia. Exp Hematol 34:1480-1489. (Pubitemid 44548118)
67. Nguyen HQ, M Selvakumaran, DA Liebermann and B Hoffman. (1995). Blocking c-Myc and Max expression inhibits proliferation and induces differentiation of normal and leukemic myeloid cells. Oncogene 11:2439-2444. (Pubitemid 26008422)
68. Lee KH, MY Chang, JI Ahn, DH Yu, SS Jung, JH Choi, YH Noh, YS Lee and MJ Ahn. (2002). Differential gene expression in retinoic acid-induced differentiation of acute promyelocytic leukemia cells, NB4 and HL-60 cells. Biochem Biophys Res Commun 296:1125-1133.
69. Alsayed Y, S Uddin, N Mahmud, F Lekmine, DV Kalvakolanu, S Minucci, G Bokoch and LC Platanias. (2001). Activation of Rac1 and the p38 mitogen-activated protein kinase pathway in response to all-trans-retinoic acid. J Biol Chem 276:4012-4019. Development